KRYS EPS Estimates
Krystal Biotech, Inc.
$319.67
-$2.50(-0.78%)
42
Overall
65
Value
20
Tech
--
Quality
Market Cap
$9.54B
Volume
125.82K
52W Range
$183.03 - $382.54
Target Price
$392.10
KRYS EPS estimates: the consensus estimate for Krystal Biotech, Inc.'s current fiscal year is $7.40 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KRYS EPS Estimates
- EPS estimate, current quarter
- $1.88
- EPS estimate, next quarter
- $1.99
- EPS estimate, current year
- $7.40
- EPS estimate, next year
- $9.00
- EPS growth, 3-year
- +48.72%
| Fiscal year | EPS |
|---|---|
| 2025 | $7.08 |
| 2024 | $3.12 |
| 2023 | $0.40 |
| 2022 | $-5.49 |
| 2021 | $-3.13 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KRYS | $319.67 | -0.8% | 125.82K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |